{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:33Z","timestamp":1792121133879,"version":"4.4.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sepsis is a life-threatening syndrome of organ dysfunction, characterized by uncontrolled inflammatory response and immune dysregulation, often leading to multiple organ failure and even death. Specialized pro-resolving mediators (SPMs), which are typically thought to be formed via consecutive steps of oxidation of polyenoic fatty acids, have been shown to suppress inflammation and promote timely resolution of inflammation. They are mainly divided into four categories: lipoxins, resolvins, protectins, and maresins. The SPMs may improve the prognosis of sepsis by modulating the immune and inflammatory balance, thereby holding promise for clinical applications. However, their biosynthetic and pharmacological properties are very complex. Through a literature review, we aim to comprehensively elucidate the protective mechanisms of different SPMs in sepsis and its organ damage, in order to provide sufficient theoretical basis for the future clinical translation of SPMs.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1444740","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:21:35Z","timestamp":1726806095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacological effects of specialized pro-resolving mediators in sepsis-induced organ dysfunction: a narrative review"],"prefix":"10.3389","volume":"15","author":[{"given":"Shujun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/biof.1691","article-title":"Specialized proresolving mediators in infection and lung injury","volume":"47","author":"Sandhaus","year":"2021","journal-title":"Biofactors"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes","volume":"81","author":"Serhan","year":"1984","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far","volume":"13","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2023.106726","article-title":"Formation of lipoxins and resolvins in human leukocytes","volume":"166","author":"Kahnt","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101034","article-title":"Maresin-1 resolution with ROR\u03b1 and LGR6","volume":"78","author":"Im","year":"2020","journal-title":"Prog Lipid Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.04.019","article-title":"Heterologously expressed formyl peptide receptor 2 (FPR2\/ALX) does not respond to lipoxin A4","volume":"85","author":"Hanson","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000422","article-title":"Multipathway in vitro pharmacological characterization of specialized proresolving G protein-coupled receptors","volume":"101","author":"Merlin","year":"2022","journal-title":"Mol Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13578-021-00734-x","article-title":"Maresin conjugates in tissue regeneration-1 suppresses ferroptosis in septic acute kidney injury","volume":"11","author":"Xiao","year":"2021","journal-title":"Cell Biosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-021-01012-w","article-title":"Lipid-derived mediators are pivotal to leukocyte and lung cell responses in sepsis and ARDS","volume":"79","author":"Nijmeh","year":"2021","journal-title":"Cell Biochem Biophys"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/mco.0000000000000896","article-title":"The role of omega-3 polyunsaturated fatty acids in the intensive care unit","volume":"26","author":"Singer","year":"2023","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.628302","article-title":"Sepsis-pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12890-022-02015-w","article-title":"Risk factors for acute respiratory distress syndrome in sepsis patients: a retrospective study from a tertiary hospital in China","volume":"22","author":"Shi","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1976","article-title":"Epidemiology and outcomes of acute lung injury","volume":"131","author":"Rubenfeld","year":"2007","journal-title":"Chest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01847-z","article-title":"TFAM-Mediated mitochondrial transfer of MSCs improved the permeability barrier in sepsis-associated acute lung injury","volume":"28","author":"Zhang","year":"2023","journal-title":"Apoptosis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12697","article-title":"LncRNA CDKN2B-AS1 interacts with LIN28B to exacerbate sepsis-induced acute lung injury by inducing HIF-1\u03b1\/NLRP3-mediated pyroptosis","volume":"39","author":"Miao","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000516192","article-title":"Pretreatment with coenzyme Q10 combined with aescin protects against sepsis-induced acute lung injury","volume":"210","author":"Ali","year":"2021","journal-title":"Cells Tissues Organs"},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13054-016-1511-2","article-title":"Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial","volume":"20","author":"Tongyoo","year":"2016","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/cc10267","article-title":"Enteral nutrition with eicosapentaenoic acid, \u03b3-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study","volume":"15","author":"Pontes-Arruda","year":"2011","journal-title":"Crit Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.23812\/20-108-a-20","article-title":"Lipoxin A4 alleviates lung injury in sepsis rats through p38\/MAPK signaling pathway","volume":"34","author":"Hu","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-562876","article-title":"Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice","volume":"124","author":"Ortiz-Mu\u00f1oz","year":"2014","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0468OC","article-title":"Attenuation of lipopolysaccharide-induced lung vascular stiffening by lipoxin reduces lung inflammation","volume":"52","author":"Meng","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0819-2","article-title":"Resolvin D1 promotes SIRT1 expression to counteract the activation of STAT3 and NF-\u03baB in mice with septic-associated lung injury","volume":"41","author":"Zhuo","year":"2018","journal-title":"Inflammation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-017-2959-x","article-title":"Xuebijing injection () and resolvin D1 synergize regulate leukocyte adhesion and improve survival rate in mice with sepsis-induced lung injury","volume":"24","author":"Zhang","year":"2018","journal-title":"Chin J Integr Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1011944","article-title":"Resolvin D2 induces anti-microbial mechanisms in a model of infectious peritonitis and secondary lung infection","volume":"13","author":"Sundarasivarao","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09151-7","article-title":"Protectin DX ameliorates inflammation in sepsis-induced acute lung injury through mediating PPAR\u03b3\/NF-\u03baB pathway","volume":"68","author":"Xia","year":"2020","journal-title":"Immunol Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-021-01793-x","article-title":"Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide-induced pulmonary endothelial glycocalyx loss via ALX\/SIRT1\/NF-kappa B axis","volume":"22","author":"Wang","year":"2021","journal-title":"Respir Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12967-023-04111-9","article-title":"Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis","volume":"21","author":"Lv","year":"2023","journal-title":"J Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3798465","article-title":"Maresin 1 mitigates inflammatory response and protects mice from sepsis","volume":"2016","author":"Li","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-018-0031-x","article-title":"Maresin 1 attenuates mitochondrial dysfunction through the ALX\/cAMP\/ROS pathway in the cecal ligation and puncture mouse model and sepsis patients","volume":"98","author":"Gu","year":"2018","journal-title":"Lab Invest"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29628","article-title":"MCTR1 alleviates lipopolysaccharide-induced acute lung injury by protecting lung endothelial glycocalyx","volume":"235","author":"Li","year":"2020","journal-title":"J Cell Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/cc6863","article-title":"Early acute kidney injury and sepsis: a multicentre evaluation","volume":"12","author":"Bagshaw","year":"2008","journal-title":"Crit Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2014.03.017","article-title":"Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury","volume":"277","author":"Chen","year":"2014","journal-title":"Toxicol Appl Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01323","article-title":"Maresin 1 mitigates sepsis-associated acute kidney injury in mice via inhibition of the NF-\u03baB\/STAT3\/MAPK pathways","volume":"10","author":"Sun","year":"2019","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.180517","article-title":"Resolvin D1 protects lipopolysaccharide-induced acute kidney injury by down-regulating nuclear factor-kappa B signal and inhibiting apoptosis","volume":"129","author":"Zhao","year":"2016","journal-title":"Chin(Engl)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.782660","article-title":"Maresin 1 attenuates lipopolysaccharide-induced acute kidney injury via inhibiting NOX4\/ROS\/NF-\u03baB pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637753","article-title":"Lipoxin A4 restores septic renal function via blocking crosstalk between inflammation and premature senescence","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.3390\/ijms222111634","article-title":"ATRvD1 attenuates renal tubulointerstitial injury induced by albumin overload in sepsis-surviving mice","volume":"22","author":"Silva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/etm.2010.170","article-title":"Suppressive action of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice","volume":"2","author":"Murakami","year":"2011","journal-title":"Exp Ther Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7499\/j.issn.1008-8830.2018.07.013","article-title":"Effect of lipoxin A4 on the expression of Toll-like receptor 4 and TNF receptor-associated factor 6 in the liver of obese rats with sepsis","volume":"20","author":"Jiang","year":"2018","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114863","article-title":"Maresin 1 protects against lipopolysaccharide\/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response","volume":"195","author":"Yang","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.865689","article-title":"Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and nrf2\/HO-1\/GPX4 activation","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2309175","article-title":"Maresin1 alleviates metabolic dysfunction in septic mice: A (1)H NMR-based metabolomics analysis","volume":"2019","author":"Hao","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318174db05","article-title":"Actual incidence of global left ventricular hypokinesia in adult septic shock","volume":"36","author":"Vieillard-Baron","year":"2008","journal-title":"Crit Care Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jatmed.2024.05.001","article-title":"Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events","volume":"3","author":"Furmanek","year":"2024","journal-title":"J Anesth Transl Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1668","article-title":"Resolvin D1 protects against sepsis-induced cardiac injury in mice","volume":"46","author":"Wang","year":"2020","journal-title":"Biofactors"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00203","article-title":"The anti-inflammatory mediator resolvin E1 protects mice against lipopolysaccharide-induced heart injury","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02080","article-title":"RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11033-020-06133-8","article-title":"Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast","volume":"48","author":"Salas-Hern\u00e1ndez","year":"2021","journal-title":"vitro. Mol Biol Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.21","article-title":"Interleukin-17 and its expanding biological functions","volume":"7","author":"Xu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674542","article-title":"[amp]]gamma;\u03b4 T\/interleukin-17A contributes to the effect of maresin conjugates in tissue regeneration 1 on lipopolysaccharide-induced cardiac injury","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/0885066620912989","article-title":"Cytokine levels in critically ill children with severe sepsis and their relation with the severity of illness and mortality","volume":"36","author":"Angurana","year":"2021","journal-title":"J Intensive Care Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13613-019-0538-3","article-title":"A multiplex analysis of sepsis mediators during human septic shock: a preliminary study on myocardial depression and organ failures","volume":"9","author":"Razazi","year":"2019","journal-title":"Ann Intensive Care"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119467","article-title":"Maresin 1 alleviates the inflammatory response, reduces oxidative stress and protects against cardiac injury in LPS-induced mice","volume":"277","author":"Li","year":"2021","journal-title":"Life Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114005","article-title":"Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function","volume":"177","author":"Yang","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181b6ed58","article-title":"Sepsis-associated encephalopathy and its differential diagnosis","volume":"37","author":"Iacobone","year":"2009","journal-title":"Crit Care Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12974-020-1701-3","article-title":"Sepsis-associated encephalopathy: a vicious cycle of immunosuppression","volume":"17","author":"Ren","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-95","article-title":"Aspirin-triggered lipoxin A4 attenuates LPS-induced pro-inflammatory responses by inhibiting activation of NF-\u03baB and MAPKs in BV-2 microglial cells","volume":"8","author":"Wang","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B65","article-title":"Resolvin D1 protects against sepsis-associated encephalopathy in mice by inhibiting neuro-inflammation induced by microglia","volume":"14","author":"Xu","year":"2022","journal-title":"Am J Transl Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.12.013","article-title":"Resolvin D1 and E1 promote resolution of inflammation in microglial cells","volume":"55","author":"Rey","year":"2016","journal-title":"vitro. Brain Behav Immun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bbadis.2009.02.013","article-title":"miR-155 gene: a typical multifunctional microRNA","volume":"1792","author":"Faraoni","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100289","article-title":"Adding fuel to fire: microRNAs as a new class of mediators of inflammation","author":"Sheedy","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nri2957","article-title":"MicroRNAs: the fine-tuners of Toll-like receptor signalling","volume":"11","author":"O\u2019Neill","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/biomedicines12010175","article-title":"Immunosuppression in sepsis: biomarkers and specialized pro-resolving mediators","volume":"12","author":"Padovani","year":"2024","journal-title":"Biomedicines"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2022.106617","article-title":"Resolvin D2 promotes host defense in a 2 - hit model of sepsis with secondary lung infection","volume":"159","author":"Walker","year":"2022","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B72","doi-asserted-by":"publisher","first-page":"7172","DOI":"10.1038\/s41467-023-41766-w","article-title":"Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples","volume":"14","author":"O\u2019Donnell","year":"2023","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186964","article-title":"Prolonged immune alteration following resolution of acute inflammation in humans","volume":"12","author":"Motwani","year":"2017","journal-title":"PloS One"},{"key":"B74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/ccm.0000000000002014","article-title":"Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit Care Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00169","article-title":"Development of an optimized LC-MS method for the detection of specialized pro-resolving mediators in biological samples","volume":"10","author":"Kutzner","year":"2019","journal-title":"Front Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2013.05.004","article-title":"Plasma levels in sepsis patients of annexin A1, lipoxin A4, macrophage inflammatory protein-3a, and neutrophil gelatinase-associated lipocalin","volume":"76","author":"Tsai","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2020.08.015","article-title":"Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake","volume":"178","author":"Calder","year":"2020","journal-title":"Biochimie"},{"key":"B78","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/cc11518","article-title":"Eliminating or blocking 12\/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury","volume":"16","author":"Rossaint","year":"2012","journal-title":"Crit Care"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0314-6","article-title":"A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis","volume":"51","author":"Kristjansson","year":"2019","journal-title":"Nat Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000483R","article-title":"Eosinophils promote corneal wound healing via the 12\/15-lipoxygenase pathway","volume":"34","author":"Ogawa","year":"2020","journal-title":"FASEB J"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05660-7","article-title":"Neonatal imprinting of alveolar macrophages via neutrophil-derived 12-HETE","volume":"614","author":"Pernet","year":"2023","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq8310","article-title":"Doubt cast on inflammation\u2019s stop signals","volume":"376","author":"Sinha","year":"2022","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1444740\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:52:53Z","timestamp":1728046373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1444740\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":82,"alternative-id":["10.3389\/fimmu.2024.1444740"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1444740","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"article-number":"1444740"}}